EPS GroupEPS Holdings, Inc.
September 2021
Launched in May 1991 with a staﬀ of only three, EPS has now grown into a corporation
with more than 7,000 employees. On this occasion, we would like to express our gratitude for your continued patronage and support over the past thirty years.
Looking back over these thirty years, our lives have been enhanced by advances inEPS is celebratingits 30th Anniversary

medical care and technology, but on the other hand, conﬂicts are relentless, and thenumber of natural disasters caused by global warming are on the rise. The unexpected
spread of the COVID-19 infection has made us rethink the roles and responsibilities of
medical and pharmaceutical product development and distribution, the area in which
the EPS Group has been involved since the companyʼ s inception, in society.
The slogan for our 30th anniversary is “New EPS begins.”
We must press forward with bolder and more aggressive restructuring of the Group inorder to remain a sought-after solutions provider. Anticipating the future of businessenvironment in constant change, EPS will evolve and move forward as we pursue
top-tier services for our clients.
We want to be the constantly evolving Ever Progressing System（EPS）that aims to bea bridge for the healthcare industry connecting everyoneʼ s health to the future. Aswell as expressing our heartfelt gratitude to all stakeholders, we hope for your continued support.

We will organize the following events/projects to commemorate the 30th anniversary of the EPSGroup. In view of the COVID-19 pandemic, the dates and times are still being finalized.
30th anniversary celebration (internal event)May 2022 (postponed by 1 year)

30th anniversary symposium

November 2022 (postponed by 1 year)

Establish EPS Shayukai association

2022

New premises TSUKUDO TERRACE

2022

2016

・Capital and business alliance agreement with SUZUKEN CO., LTD.

1991

・EPS Tokyo Inc. was established for Clinical trials related software development &Sales.

2015

1999

・Transferred to a holding company system and changed the company name to EPS Holdings, Inc.

・Launched CRO and software development
business in China.
・Launched SMO (Site Management Organization) business to support clinical trial-related
operations of medical institutions.

1996

・Changed the company
name to EPS Co., Ltd.

2010

・Started Pharmaceutical products sales business in China.

2001

・Changed the company nameto EPS Corporation
・EPS Corporation listed on
JASDAQ.

2006

・EPS Corporation listed on
the 1st section of the Tokyo
Stock Exchange.

2003

1993

・Launched CRO (Contract Research Organization) business by starting case registration and drug allocation services for clinical
trials. Developed a large-scaled clinical trial
support system for the drug pharmaco-epidemiology research by Ministry of Healthand Welfare (currently, MHLW).

2020

・Participation in joint
development of DNA
vaccine for new coronavirus (COVID-19).

・Launched CRO business inSoutheast Asia

2000

・Started CSO (Contract Sales Organization ) business, which undertakes
MR (Medical Representative) operations for pharmaceutical companies.

Major Group Companies of EPS

EPS Holdings, Inc.
EPS Corporation
EP Croit Co., Ltd.
EP-CRSU Co., Ltd.
EP Mediate Co., Ltd.
EP Yamanashi Co., Ltd.
Micren Healthcare Co., Ltd.
EP-SOGO Co., Ltd.
EP-PharmaLine Co., Ltd.
EP-Force Co., Ltd.
ES-Link Co., Ltd.
EPS International Holdings Co., Ltd.
EPS EKISHIN Co., Ltd.
EP Trading Co., Ltd.
EPS China Co., Ltd.
EPS Creative Health Technology Group Limited
EPS Digital-Share Co., Ltd.
EPBiz Co., Ltd.